Bacteriophages battle superbugs

July 18, 2013, Norwich BioScience Institutes
This is Clostridium difficile bacteriophage ΦCD27. Credit: IFR

IFR microbiologists are reinvigorating a way of battling C. difficile infections that they hope will help overcome the growing problem of antibiotic resistant superbugs in hospitals.

Our digestive system is home to trillions of bacteria, which are crucial to our overall health, through helping us digest food and battling potentially harmful microbes. When we take to combat bacterial infections these can also be killed off, leaving us at risk of by harmful bacteria. Clostridium difficile is one of these and is the leading cause of in England and Wales. Although the number of C. difficile infections is dropping, treating them is becoming harder as it becomes more resistant to antibiotics. New ways of controlling C. difficile infections are desperately needed to replace ineffective antibiotics, and bacteriophages are one such technology being investigated.

Bacteriophages are naturally occurring viruses that target bacteria. Bacteriophage therapy is not a new idea; it was being developed not long after their discovery at the start of the 20th century. However, after the discovery of penicillin and other antibiotics the research into the use of phages was abandoned in the West but its application continues in Eastern Europe, particularly in Georgia. Now that the bacterial resistance to antibiotics is becoming such a large problem, there is renewed interest in developing therapy.

For use as a therapy, the bacteriophage must not affect any of the hundreds of different bacterial species that make up a healthy human microbiota. Researchers at the IFR had previously discovered and isolated a bacteriophage that specifically targets C. difficile. The new study, published in the journal Anaerobe, looked to assess how effective using this phage might be in combatting C. difficile infections.

The researchers used a model of the human colon, set up to mimic that of an elderly person in hospital. Antibiotics were given in the same way as in hospital, disrupting the normal balance of bacteria and allowing C. difficile to establish itself, and then produce the toxins that make C. difficile infections so dangerous.

The study showed that the administration of a specific bacteriophage significantly reduced the number of C. difficile cells and also the amount of toxin produced, without significantly affecting the other members of the gut microbiota. This suggests that bacteriophages could have great potential for use to combat C. difficile infections in hospital settings.

The phage wasn't, however, able to kill off all of the C. difficile cells. This was because this bacteriophage, like many others, is able to insert its own DNA into the bacterial chromosome – a process known as lysogeny. This makes the resistant to further bacteriophage attack.

Interestingly, in some cases the lysogeny seemed to prevent the C difficile cells from producing the toxin. So although all of the cells aren't killed, those that survive are a lot less dangerous. This may give clinicians more time to get C. difficile infections under control.

This bacteriophage shows considerable promise as a new therapeutic agent to control C. difficile infections in hospitals, with potential to provide a new weapon that is desperately needed in the battle against .

Explore further: Probiotics prevent diarrhoea related to antibiotic use

More information: Anaerobe S1075-9964(13)00082-6. doi: 10.1016/j.anaerobe.2013.05.001

Related Stories

Probiotics prevent diarrhoea related to antibiotic use

May 30, 2013
Probiotic supplements have the potential to prevent diarrhoea caused by antibiotics, according to a new Cochrane systematic review. The authors studied Clostridium difficile (C. difficile) infections in patients taking antibiotics ...

Tuning natural antimicrobials to improve their effectiveness at battling superbugs

August 22, 2011
Ongoing research at the Institute of Food Research, which is strategically funded by BBSRC, is exploring the use of virus-produced proteins that destroy bacterial cells to combat potentially dangerous microbial infections. ...

Rhode Island Hospital reduces incidence of hospital-associated C. difficile by 70 percent

June 20, 2013
Rhode Island Hospital has reduced the incidence of hospital-associated Clostridium difficile (C. difficile) infections by 70 percent and reduced annual associated mortality in patients with hospital-associated C. difficile ...

Unnecessary antimicrobial use increases risk of recurrent infectious diarrhea

January 9, 2013
The impact of antibiotic misuse has far-reaching consequences in healthcare, including reduced efficacy of the drugs, increased prevalence of drug-resistant organisms, and increased risk of deadly infections. A new study ...

More antibiotic use tied to rise in diarrheal infections in hospitals, study finds

October 22, 2012
(HealthDay)—Greater use of antibiotics is the main reason for an increase in the number and severity of Clostridium difficile infections among hospitalized children and elderly people, researchers report.

University of Minnesota startup to treat challenging bacterial infection

May 16, 2012
A live biological preparation developed by University of Minnesota researchers could put a stop to an increasingly prevalent, and sometimes deadly, infection caused by the bacterium Clostridium difficile. CIPAC Limited, based ...

Recommended for you

Fresh approach to tuberculosis vaccine offers better protection

January 17, 2018
A unique platform that resulted in a promising HIV vaccine has also led to a new, highly effective vaccine against tuberculosis that is moving toward testing in humans.

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

Newly-discovered TB blood signal provides early warning for at-risk patients

January 17, 2018
Tuberculosis can be detected in people with HIV infection via a unique blood signal before symptoms appear, according to a new study by researchers from the Crick, Imperial College London and the University of Cape Town.

New study validates clotting risk factors in chronic kidney disease

January 17, 2018
In late 2017, researchers from Boston University School of Medicine (BUSM) discovered and published (Science Translational Medicine, (9) 417, Nov 2017) a potential treatment target to prevent chronic kidney disease (CKD) ...

New study offers insights on genetic indicators of COPD risk

January 16, 2018
Researchers have discovered that genetic variations in the anatomy of the lungs could serve as indicators to help identify people who have low, but stable, lung function early in life, and those who are particularly at risk ...

Previous influenza virus exposures enhance susceptibility in another influenza pandemic

January 16, 2018
While past exposure to influenza A viruses often builds immunity to similar, and sometimes different, strains of the virus, Canadian researchers are calling for more attention to exceptions to that rule.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.